194 related articles for article (PubMed ID: 37173959)
1. Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy.
Hogh-Binder SA; Klein D; Wolfsperger F; Huber SM; Hennenlotter J; Stenzl A; Rudner J
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173959
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
Trivigno D; Essmann F; Huber SM; Rudner J
Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
[TBL] [Abstract][Full Text] [Related]
4. Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers.
Sulkshane P; Pawar SN; Waghole R; Pawar SS; Rajput P; Uthale A; Oak S; Kalkar P; Wani H; Patil R; Nair S; Rane P; Teni T
Br J Cancer; 2021 Aug; 125(4):547-560. PubMed ID: 34079080
[TBL] [Abstract][Full Text] [Related]
5. The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition.
Peddaboina C; Jupiter D; Fletcher S; Yap JL; Rai A; Tobin RP; Jiang W; Rascoe P; Rogers MK; Smythe WR; Cao X
BMC Cancer; 2012 Nov; 12():541. PubMed ID: 23171055
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP9X regulates the invasion of prostate cancer cells by regulating the ERK pathway and mitochondrial dynamics.
Zhang J; Wang J; Luan T; Zuo Y; Chen J; Zhang H; Ye Z; Wang H; Hai B
Oncol Rep; 2019 Jun; 41(6):3292-3304. PubMed ID: 31002345
[TBL] [Abstract][Full Text] [Related]
7. Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
Peterson LF; Sun H; Liu Y; Potu H; Kandarpa M; Ermann M; Courtney SM; Young M; Showalter HD; Sun D; Jakubowiak A; Malek SN; Talpaz M; Donato NJ
Blood; 2015 Jun; 125(23):3588-97. PubMed ID: 25814533
[TBL] [Abstract][Full Text] [Related]
8. USP9X Increased Tumor Angiogenesis in Mantle Cell Lymphoma by Upregulation of CCND1-Mediated SOX11.
Huang G; Liao J; Wang M; Huang Y; Tang M; Hao Y
Mediterr J Hematol Infect Dis; 2022; 14(1):e2022048. PubMed ID: 35865393
[TBL] [Abstract][Full Text] [Related]
9. Usp9x- and Noxa-mediated Mcl-1 downregulation contributes to pemetrexed-induced apoptosis in human non-small-cell lung cancer cells.
Yan J; Zhong N; Liu G; Chen K; Liu X; Su L; Singhal S
Cell Death Dis; 2014 Jul; 5(7):e1316. PubMed ID: 24991768
[TBL] [Abstract][Full Text] [Related]
10. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1.
Kushwaha D; O'Leary C; Cron KR; Deraska P; Zhu K; D'Andrea AD; Kozono D
Cancer Biol Ther; 2015; 16(3):392-401. PubMed ID: 25692226
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
[TBL] [Abstract][Full Text] [Related]
12. Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth.
Pal A; Dziubinski M; Di Magliano MP; Simeone DM; Owens S; Thomas D; Peterson L; Potu H; Talpaz M; Donato NJ
Neoplasia; 2018 Feb; 20(2):152-164. PubMed ID: 29248719
[TBL] [Abstract][Full Text] [Related]
13. Combined inhibition of Bcl-2/Bcl-xL and Usp9X/Bag3 overcomes apoptotic resistance in glioblastoma in vitro and in vivo.
Karpel-Massler G; Shu C; Chau L; Banu M; Halatsch ME; Westhoff MA; Ramirez Y; Ross AH; Bruce JN; Canoll P; Siegelin MD
Oncotarget; 2015 Jun; 6(16):14507-21. PubMed ID: 26008975
[TBL] [Abstract][Full Text] [Related]
14. USP9X expression is functionally related to laryngeal cancer.
Wan YF; Zhang CY; Cheng XW; Liu LS; Zhou T; Gao JK; Zhu HQ; Liu YH
J Cancer; 2023; 14(4):591-599. PubMed ID: 37057289
[TBL] [Abstract][Full Text] [Related]
15. Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors.
Bianchetti E; Bates SJ; Carroll SL; Siegelin MD; Roth KA
Sci Rep; 2018 Nov; 8(1):17390. PubMed ID: 30478285
[TBL] [Abstract][Full Text] [Related]
16. Noxa controls Mule-dependent Mcl-1 ubiquitination through the regulation of the Mcl-1/USP9X interaction.
Gomez-Bougie P; Ménoret E; Juin P; Dousset C; Pellat-Deceunynck C; Amiot M
Biochem Biophys Res Commun; 2011 Sep; 413(3):460-4. PubMed ID: 21907705
[TBL] [Abstract][Full Text] [Related]
17. Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells.
Palve VC; Teni TR
Radiat Oncol; 2012 Aug; 7():135. PubMed ID: 22873792
[TBL] [Abstract][Full Text] [Related]
18. IRS-2 deubiquitination by USP9X maintains anchorage-independent cell growth via Erk1/2 activation in prostate carcinoma cell line.
Furuta H; Yoshihara H; Fukushima T; Yoneyama Y; Ito A; Worrall C; Girnita A; Girnita L; Yoshida M; Asano T; Komada M; Kataoka N; Chida K; Hakuno F; Takahashi SI
Oncotarget; 2018 Sep; 9(74):33871-33883. PubMed ID: 30338032
[TBL] [Abstract][Full Text] [Related]
19. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
[TBL] [Abstract][Full Text] [Related]
20. Mcl-1 targeting could be an intriguing perspective to cure cancer.
De Blasio A; Vento R; Di Fiore R
J Cell Physiol; 2018 Nov; 233(11):8482-8498. PubMed ID: 29797573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
